𝔖 Bobbio Scriptorium
✦   LIBER   ✦

CXCL13 and B-cell activating factor as putative biomarkers in systemic sclerosis

✍ Scribed by Wutte, N.; Kovacs, G.; Berghold, A.; Reiter, H.; Aberer, W.; Aberer, E.


Book ID
125466516
Publisher
John Wiley and Sons
Year
2013
Tongue
English
Weight
140 KB
Volume
169
Category
Article
ISSN
0007-0963

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Altered blood B lymphocyte homeostasis i
✍ Shinichi Sato; Manabu Fujimoto; Minoru Hasegawa; Kazukiko Takehara πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 141 KB

## Abstract ## Objective To determine phenotypic and functional abnormalities of blood B cell subsets in patients with systemic sclerosis (SSc). ## Methods Cell surface marker expression was determined by flow cytometry. Spontaneous apoptosis was evaluated by annexin V expression with flow cytom

Preliminary clinical measurement of the
✍ Zhou Lin; Yang Dan-Rong; Tu Xiao-Qing; Wang Hao; Geng Hong-Lian; Kong Xian-Tao; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 149 KB

## Abstract It has recently been found that excessive serum B‐cell activating factor (BAFF) production triggers severe autoimmune disorders in mice resembling systemic lupus erythematosus (SLE). Whether such dysregulation in circulating levels of BAFF results from overexpression of BAFF gene in cli